In a surprising move, Lars Fruergaard Jørgensen is stepping down as CEO of Novo Nordisk after years of leading the company through a successful phase in obesity and diabetes medications. As the search for his successor begins, what does this mean for the future of the pharmaceutical giant?
After a steep 18% drop, UnitedHealth Group's shares saw a modest rebound as analysts maintain positive ratings despite the company withdrawing its guidance and the CEO's resignation. Will the stock recover?
In a shocking turn of events, Andrew Witty has resigned as CEO of UnitedHealth Group, triggering a 17% stock drop and raising concerns over the company's future amid rising medical costs and a recent antitrust lawsuit.
In a surprising move, UnitedHealth Group CEO Andrew Witty has stepped down, citing personal reasons. Board chairman Stephen Hemsley takes over as the company navigates significant industry challenges.
In a surprising turn of events, Stephen Hemsley is back as CEO of UnitedHealth after the abrupt departure of current leader Witty. The company faces significant challenges, including recent cyberattacks and rising medical costs.
In a dramatic turn of events, 23andMe has filed for Chapter 11 bankruptcy, leading to the immediate resignation of CEO Anne Wojcicki. The company plans to sell its assets while navigating financial turmoil and ongoing efforts to safeguard customer data.
In a surprising move, Amtrak CEO Stephen Gardner has announced his resignation, citing the need for the company to maintain confidence amid the Trump administration's funding pressures on mass transit systems. Speculation grows over the implications for future rail initiatives.
In a surprising turn of events, Kroger's CEO Rodney McMullen has resigned following an investigation into his personal conduct. The board found his actions inconsistent with company ethics, impacting Kroger's turbulent period post-merger collapse with Albertsons. Ronald Sargent steps in as interim CEO.
In a surprising turn of events, Kroger CEO Rodney McMullen has stepped down following a probe into his personal conduct. The investigation, which found inconsistencies with the company's ethics policy, was unrelated to business operations. Ron Sargent will serve as interim CEO.
